Travere CEO Eric Dube on deciding to leave; Roche tees up a board seat for ex-Takeda chief
On Dec. 1, Travere Therapeutics will have a new CEO for the first time in almost eight years, as Eric Dube hands the baton to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Source link







